JCIA
ANIK icon

Jackson Creek Investment Advisors’s Anika Therapeutics ANIK Stock Holding History

Jackson Creek Investment Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-24,764
Closed -$1.05M – 304
2021
Q3 		$1.05M Buy
24,764
+239
+1% +$9.84K 0.39% 122
2021
Q2 		$1.06M Buy
+24,525
New +$1.04M 0.39% 116

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Jackson Creek Investment Advisors's ANIK Position: Q4 2021 in Review

Jackson Creek Investment Advisors sold out of Anika Therapeutics (ANIK) in Q4 2021, closing a stake of 24,764 shares — an estimated $1.05M sold.

Jackson Creek Investment Advisors first reported a position in ANIK in Q2 2021 and held it in 2 quarters. The position peaked at $1.06M in Q2 2021. 127 funds tracked by Wall St. Rank hold ANIK as of Q4 2021.

  • Jackson Creek Investment Advisors reported no remaining Anika Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 24,764 Anika Therapeutics shares in Q4 2021, an estimated $1.05M.
  • Jackson Creek Investment Advisors first reported a position in Anika Therapeutics in Q2 2021 and held it in 2 quarters.
  • Jackson Creek Investment Advisors's Anika Therapeutics position peaked at $1.06M in Q2 2021.
  • 127 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2021.

Based on Jackson Creek Investment Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.